Shopping Cart
Remove All
Your shopping cart is currently empty
RNPA1000 is an attractive antimicrobial development candidate and RnpA inhibitor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $732 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,090 | 6-8 weeks | 6-8 weeks |
| Description | RNPA1000 is an attractive antimicrobial development candidate and RnpA inhibitor. |
| In vitro | RnpA inhibitor The antibiotic vancomycin and a novel Staphylococcus aureus RnpA inhibitor under pre-clinical development, RNPA1000, were included in these studies. Longer incubations allowed for Staphylococcus aureus colonies to form near the vancomycin-infused cement, indicating that vancomycin may not be suitable for long-term biofilm inhibition in comparison to RNPA1000. Loading glass polyalkenoate cement with either 20-30% RNPA1000 or vancomycin prevented bacterial growth. |
| Molecular Weight | 464.31 |
| Formula | C23H18BrN3O3 |
| Cas No. | 359600-10-5 |
| Smiles | Cc1cc(\C=C(/C#N)C(=O)Nc2cccc(Br)c2)c(C)n1-c1ccc(cc1)C(O)=O |
| Relative Density. | 1.39 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.